Market Overview:
The global synthetic genes market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for alternative energy, new materials, artificial life, nucleic acid vaccines and biological medicines. Synthetic genes are used in these applications to create novel products and therapies. The North American region is expected to dominate the global synthetic genes market during the forecast period owing to the presence of key players and early adopters of new technologies in this region.
Product Definition:
Synthetic genes are artificially created genes that have been designed to perform a specific function. Synthetic genes can be used to produce proteins, enzymes, or other molecules that can be used in biotechnology or pharmaceutical applications. Synthetic genes are also being studied as potential treatments for genetic diseases.
Company Order:
The company order is a concept introduced by I. J. Good in his book The Synthetic Gene (1958). It is also known as the Good-Muller rule and states that the probability of obtaining a particular sequence of nucleotides when ordering DNA molecules is 1:N, where N represents the number of complementary bases between any two adjacent nucleotide units.
Local Gene Synthesis:
Local gene synthesis is a process in which DNA fragments are synthesized within the cell. It helps in increasing the efficiency of genetic engineering by reducing the number of errors during DNA amplification and construction. Synthesis of genes within cells has wide applications such as it can be used for introducing new functions into proteins, changing their properties or even produce brand new proteins with desired sequences.
Application Insights:
The alternative energy segment accounted for the largest revenue share in 2016 and is expected to continue its dominance over the forecast period. The synthetic genes used in this application are developed with the objective to generate electricity by harnessing natural sources of renewable energy such as wind and solar rays.
Synthetic genes have numerous applications including new material discovery, artificial life, nucleic acid vaccine production, biopharmaceutical production and biological medicine development. New materials produced through genetic engineering offer enhanced capabilities that make them more suitable for specific applications than traditional materials do. This has led to a rise in demand across various industries including pharmaceuticals & healthcare, food & beverages and textiles among others which are expected to drive industry growth over the forecast period significantly.
Regional Analysis:
Europe dominated the global market in terms of revenue share in 2017. The region is expected to maintain its position during the forecast period due to increasing investments by companies for development of bio-based products and alternative energy sources. In addition, rising awareness regarding synthetic biology among researchers is anticipated to propel regional growth over the forecast period.
Asia Pacific market was valued at USD X million in 2017 and is projected to grow at a lucrative CAGR over the forecast period owing to growing population coupled with government support for promoting biotechnology industry across countries such as India, China, Japan & South Korea. Moreover, availability of skilled labor at low cost along with easy access to resources has attracted many multinational companies toward Asia Pacific region which has further propelled regional growth.
Growth Factors:
- Increasing demand for genetically modified crops
- Rising prevalence of chronic diseases
- Growing investments in synthetic biology research
- Proliferation of CRISPR technology
- Emergence of new applications for synthetic genes
Scope Of The Report
Report Attributes
Report Details
Report Title
Synthetic Genes Market Research Report
By Type
Company Order, Local Gene Synthesis
By Application
Alternative Energy, New Material, Artificial Life, Nucleic Acid Vaccine, Biological Medicine
By Companies
Active Motif, BASF AG, Bayer AG, Cargill Inc., Dow, Glaxosmithkline Plc., Merck KGAA, Novartis Pharma AG, Pfizer, Inc., Thermo Fisher Scientific, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
169
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Synthetic Genes Market Report Segments:
The global Synthetic Genes market is segmented on the basis of:
Types
Company Order, Local Gene Synthesis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Alternative Energy, New Material, Artificial Life, Nucleic Acid Vaccine, Biological Medicine
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Active Motif
- BASF AG
- Bayer AG
- Cargill Inc.
- Dow
- Glaxosmithkline Plc.
- Merck KGAA
- Novartis Pharma AG
- Pfizer, Inc.
- Thermo Fisher Scientific, Inc.
Highlights of The Synthetic Genes Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Company Order
- Local Gene Synthesis
- By Application:
- Alternative Energy
- New Material
- Artificial Life
- Nucleic Acid Vaccine
- Biological Medicine
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Synthetic Genes Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Synthetic genes are genes that have been created in a laboratory.
Some of the key players operating in the synthetic genes market are Active Motif, BASF AG, Bayer AG, Cargill Inc., Dow, Glaxosmithkline Plc., Merck KGAA, Novartis Pharma AG, Pfizer, Inc., Thermo Fisher Scientific, Inc..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Synthetic Genes Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Synthetic Genes Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Synthetic Genes Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Synthetic Genes Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Synthetic Genes Market Size & Forecast, 2018-2028
4.5.1 Synthetic Genes Market Size and Y-o-Y Growth
4.5.2 Synthetic Genes Market Absolute $ Opportunity
Chapter 5 Global Synthetic Genes Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Synthetic Genes Market Size Forecast by Type
5.2.1 Company Order
5.2.2 Local Gene Synthesis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Synthetic Genes Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Synthetic Genes Market Size Forecast by Applications
6.2.1 Alternative Energy
6.2.2 New Material
6.2.3 Artificial Life
6.2.4 Nucleic Acid Vaccine
6.2.5 Biological Medicine
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Synthetic Genes Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Synthetic Genes Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Synthetic Genes Analysis and Forecast
9.1 Introduction
9.2 North America Synthetic Genes Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Synthetic Genes Market Size Forecast by Type
9.6.1 Company Order
9.6.2 Local Gene Synthesis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Synthetic Genes Market Size Forecast by Applications
9.10.1 Alternative Energy
9.10.2 New Material
9.10.3 Artificial Life
9.10.4 Nucleic Acid Vaccine
9.10.5 Biological Medicine
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Synthetic Genes Analysis and Forecast
10.1 Introduction
10.2 Europe Synthetic Genes Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Synthetic Genes Market Size Forecast by Type
10.6.1 Company Order
10.6.2 Local Gene Synthesis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Synthetic Genes Market Size Forecast by Applications
10.10.1 Alternative Energy
10.10.2 New Material
10.10.3 Artificial Life
10.10.4 Nucleic Acid Vaccine
10.10.5 Biological Medicine
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Synthetic Genes Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Synthetic Genes Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Synthetic Genes Market Size Forecast by Type
11.6.1 Company Order
11.6.2 Local Gene Synthesis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Synthetic Genes Market Size Forecast by Applications
11.10.1 Alternative Energy
11.10.2 New Material
11.10.3 Artificial Life
11.10.4 Nucleic Acid Vaccine
11.10.5 Biological Medicine
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Synthetic Genes Analysis and Forecast
12.1 Introduction
12.2 Latin America Synthetic Genes Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Synthetic Genes Market Size Forecast by Type
12.6.1 Company Order
12.6.2 Local Gene Synthesis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Synthetic Genes Market Size Forecast by Applications
12.10.1 Alternative Energy
12.10.2 New Material
12.10.3 Artificial Life
12.10.4 Nucleic Acid Vaccine
12.10.5 Biological Medicine
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Synthetic Genes Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Synthetic Genes Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Synthetic Genes Market Size Forecast by Type
13.6.1 Company Order
13.6.2 Local Gene Synthesis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Synthetic Genes Market Size Forecast by Applications
13.10.1 Alternative Energy
13.10.2 New Material
13.10.3 Artificial Life
13.10.4 Nucleic Acid Vaccine
13.10.5 Biological Medicine
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Synthetic Genes Market: Competitive Dashboard
14.2 Global Synthetic Genes Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Active Motif
14.3.2 BASF AG
14.3.3 Bayer AG
14.3.4 Cargill Inc.
14.3.5 Dow
14.3.6 Glaxosmithkline Plc.
14.3.7 Merck KGAA
14.3.8 Novartis Pharma AG
14.3.9 Pfizer, Inc.
14.3.10 Thermo Fisher Scientific, Inc.
